Primary IgA Nephropathy; Autoimmune Hepatitis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Primary IgA Nephropathy; Autoimmune Hepatitis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 1

NCT06922305

Relative Bioavailability Study of HR19042 in Healthy Subjects

This is a single-center, randomized, open-label, three-period, dual Latin square crossover study. Primary Objective： 1. To evaluate the oral relative bioavail…

China18 participantsStarted 2023-12-27

Treatment: HR19042 Capsule, Tarpeyo®, Budenofalk®